Zheng Kang Lum

Zheng Kang Lum

Auto-generated profile, based on publicly available information

Zheng Kang Lum

Department of Pharmacy, Faculty of Science, National University of Singapore

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Journal of Global Oncology
Verified
Journal Article
Open access
ACAlexandre Chan
Alexandre Chan
ZLZheng Kang Lum
Zheng Kang Lum
TNTerence Ng
Terence Ng
TETewodros Eyob
Tewodros Eyob
XWXiao Jun Wang
Xiao Jun Wang
GFGilbert Fan
Gilbert Fan
Purpose With the long-term goal to optimize post-treatment cancer care in Asia, we conducted a qualitative study to gather in-depth descriptions from multiethnic Asian breast cancer survivors on their perceptions and experiences of cancer survivorship and their perceived barriers to post-treatment follow-up. Methods Twenty-four breast cancer survivors in Singapore participated in six structured focus group discussions. The focus group discussions were voice recorded, transcribed verbatim, and analyzed by thematic analysis. Results Breast cancer survivors were unfamiliar with and disliked the term “survivorship,” because it implies that survivors had undergone hardship during their treatment. Cognitive impairment and peripheral neuropathy were physical symptoms that bothered survivors the most, and many indicated that they experienced emotional distress during survivorship, for which they turned to religion and peers as coping strategies. Survivors indicated lack of consultation time and fear of unplanned hospitalization as main barriers to optimal survivorship care. Furthermore, survivors indicated that they preferred receipt of survivorship care at the specialty cancer center. Conclusion Budding survivorship programs in Asia must take survivor perspectives into consideration to ensure that survivorship care is fully optimized within the community.

9 March 2020 in The Annals of Family Medicine
Verified
Journal Article
Open access
PDF file
ZLZheng Kang Lum
Zheng Kang Lum
ZKZi Rui Khoo
Zi Rui Khoo
WTWei Yann See Toh
Wei Yann See Toh
SKShaikh Abdul Kader Kamaldeen
Shaikh Abdul Kader Kamaldeen
ASAbdul Shakoor
Abdul Shakoor
JLJoyce Yu-Chia Lee
Joyce Yu-Chia Lee
PURPOSE We aimed to evaluate the efficacy and safety of use of the Fasting Algorithm for Singaporeans with Type 2 Diabetes (FAST) during Ramadan. METHODS We performed a prospective, multicenter, randomized controlled trial. The inclusion criteria were age ≥21 years, baseline glycated hemoglobin (HbA1c) level ≤9.5%, and intention to fast for ≥10 days during Ramadan. Exclusion criteria included baseline estimated glomerular filtration rate <30 mL/min, diabetes-related hospitalization, and short-term corticosteroid therapy. Participants were randomized to intervention (use of FAST) or control (usual care without FAST) groups. Efficacy outcomes were HbA1c level and fasting blood glucose and postprandial glucose changes, and the safety outcome was incidence of major or minor hypoglycemia during the Ramadan period. Glycemic variability and diabetes distress were also investigated. Linear mixed models were constructed to assess changes. RESULTS A total of 97 participants were randomized (intervention: n = 46, control: n = 51). The HbA1c improvement during Ramadan was 4 times greater in the intervention group (−0.4%) than in the control group (−0.1%) (P = .049). The mean fasting blood glucose level decreased in the intervention group (−3.6 mg/dL) and increased in the control group (+20.9 mg/dL) (P = .034). The mean postprandial glucose level showed greater improvement in the intervention group (−16.4 mg/dL) compared to the control group (−2.3 mg/dL). There were more minor hypoglycemic events based on self-monitered blood glucose readings in the control group (intervention: 4, control: 6; P = .744). Glycemic variability was not significantly different between the 2 groups (P = .284). No between-group differences in diabetes distress were observed (P = .479). CONCLUSIONS Our findings emphasize the importance of efficacious, safe, and culturally tailored epistemic tools for diabetes management.

1 October 2018 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
ZLZheng Kang Lum
Zheng Kang Lum
WTWei Yann See Toh
Wei Yann See Toh
SLSze Mian Lim
Sze Mian Lim
KRKhairul Dzakirin Bin Rusli
Khairul Dzakirin Bin Rusli
SSShaikh Abdul Kader Kamaldeen Abdul Shakoor
Shaikh Abdul Kader Kamaldeen Abdul Shakoor
JLJoyce Yu-Chia Lee
Joyce Yu-Chia Lee
Empowerment plays significant roles in the complex management of type 2 diabetes. International guidelines have provided recommendations on management of Muslims who fast during Ramadan. However, there remains a lack of patient-centered epistemic tool to empower healthcare providers and patients in managing diabetes during Ramadan. This study discussed the development and evaluation of such tool. The collaborative algorithm was developed with reference to the nominal group technique by a board-certified clinical pharmacist and discussed with endocrinologists, nurses, and family physicians. The empowerment component of the algorithm was developed based on the Basic Psychological Needs Theory. The algorithm was evaluated through a randomized controlled trial. Glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) levels and safety profiles in terms of hypoglycemic events were assessed. The collaborative algorithm was developed with four components: screening, education, dose modification by healthcare provider, and dose adjustment by patient. A total of 62 individuals were recruited, with 30 and 32 randomized into the intervention and control groups, respectively. The mean age was 58.4 years, with majority being females (67.7%). There was a reduction in mean HbA1c from 7.9% ± 0.9% to 7.5% ± 0.8% ( P < 0.001) in the intervention group, while no significant difference was observed in the control group ( P = 0.270). FPG ( P < 0.001) and PPG ( P = 0.002) also improved significantly in the intervention group. There were no major hypoglycemic events and minor hypoglycemia comparable between both groups ( P = 0.465). The collaborative algorithm incorporated empowerment and promoted shared decision-making in diabetes management, hence promoting safe and effective fasting.

29 July 2019 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
ZLZheng Kang Lum
Zheng Kang Lum
MSMelanie Yee Lee Siaw
Melanie Yee Lee Siaw
MLMichelle Jia Xin Lee
Michelle Jia Xin Lee
ZKZexuan Koh
Zexuan Koh
PZParry Quan Zhang
Parry Quan Zhang
JLJoyce Yu-Chia Lee
Joyce Yu-Chia Lee


8 March 2023 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
ZLZheng Kang Lum
Zheng Kang Lum
YXYingqi Xu
Yingqi Xu
Paul John GallagherPaul John Gallagher
Paul John Gallagher
JLJoyce Yu-Chia Lee
Joyce Yu-Chia Lee
Objective: This scoping review aimed to map the extent and range of evidence on the clinical activities performed and types of outcomes evaluated in pharmacist‐involved collaborative care models for diabetes management.Methods: This scoping review was guided by the five‐stage methodological framework developed by Arksey and O'Malley. Publications in the English language were identified from PubMed, EMBASE, and CINAHL and the databases were searched from inception to 31 May 2022. Abstracts, conference proceedings, brief reports, and commentaries were excluded. Key search terms were “interprofessional collaborative care,” “pharmacist,” “type 2 diabetes,” and “outcome.” Microsoft Excel was used for data charting and descriptive computations were conducted using the Statistical Package for Social Sciences.Results: A total of 208 articles were identified, and after excluding 178 articles (and duplicates), 30 articles were reviewed. Most of the studies (56.7%) were conducted in the United States of America and were randomized controlled trials (50.0%) followed by cohort studies (36.7%). The most common clinical activity identified was provision of health‐ and medication‐related education (80.0%), followed by lifestyle counseling (76.7%) and development of individualized care plan and goal setting (63.3%). Other clinical activities were review of laboratory records, medication review and dose adjustments, optimization of medication adherence, minimization of drug‐related problems, identify referral to other care providers, and conduct physical assessments. HbA1c was the most reported clinical outcome (n = 26, 86.7%), with 11 studies evaluating patient‐reported outcomes (PROs) such as medication adherence, diabetes knowledge, self‐care, quality of life, diabetes distress, and treatment satisfaction.Conclusion: Clinical activities performed by pharmacists were heterogenous across studies and based on patients' needs. While pharmacist‐involved collaborative care models were posited as person‐centric outcome, PROs were lacking in most studies. Evaluating PROs are essential in guiding the implementation of such people‐centric care models.